Prediction of Post-Stroke Cognitive Impairment Based on Iron Metabolism Parameters: Results From A Prospective Study
- PMID: 40514564
- DOI: 10.1007/s12035-025-05142-7
Prediction of Post-Stroke Cognitive Impairment Based on Iron Metabolism Parameters: Results From A Prospective Study
Abstract
Disruption of iron homeostasis is associated with the pathogenesis of neurological disorders. This study aims to elucidate the correlation between serum iron metabolism profiles and the occurrence of post-stroke cognitive impairment (PSCI). Acute ischemic stroke (AIS) patients (n = 500) were enrolled, and serum iron metabolism parameters were collected at baseline. Cognitive abilities, including global cognition, episodic memory, language proficiency, attention, and executive function, were successfully assessed in participants six months after the AIS event (n = 224, mean age = 62). Multivariate logistic regression analysis was employed to screen for iron metabolism indicators influencing PSCI. A general linear model was used to analyze the correlation between total iron-binding capacity (TIBC) and overall cognitive function as well as performance in various cognitive domains. Additionally, we constructed a nomogram model to predict PSCI risk and validated its performance. The results revealed that the TIBC levels were significantly lower in the PSCI group. Elevated TIBC levels may represent a potential protective factor against PSCI development (OR = 0.940, 95% CI = 0.894-0.989, p = 0.018). Furthermore, higher serum TIBC levels were associated with better overall cognitive function, episodic memory, and language proficiency. The nomogram model constructed using age, gender, education level, National Institutes of Health Stroke Scale (NIHSS) score, and TIBC variables demonstrated good predictive performance for PSCI risk (AUC = 0.761, 95%CI = 0.696-0.825). In conclusion, serum TIBC is a potential biomarker for PSCI and is closely associated with cognitive ability.
Keywords: Acute ischemic stroke; Iron metabolism; Post-stroke cognitive impairment; Total iron binding capacity.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethics Approval and Consent to Participate: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Hospital of Jilin University. Informed consent was obtained from all individual participants included in the study. Clinical Trial Number: Not applicable.
Similar articles
-
Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment.Int J Stroke. 2024 Oct;19(8):888-897. doi: 10.1177/17474930241238637. Epub 2024 Mar 21. Int J Stroke. 2024. PMID: 38425239
-
Exploring the Relationship Between Serum Neuronal Pentraxin 2 and Poststroke Cognitive Impairment in Patients With First-Episode Acute Ischemic Stroke.Brain Behav. 2025 Feb;15(2):e70305. doi: 10.1002/brb3.70305. Brain Behav. 2025. PMID: 39924979 Free PMC article.
-
Serum neurofilament heavy chain predicts post-stroke cognitive impairment.Sci Rep. 2025 Apr 19;15(1):13556. doi: 10.1038/s41598-025-96952-1. Sci Rep. 2025. PMID: 40253401 Free PMC article.
-
Prediction of poststroke cognitive impairment based on the systemic inflammatory response index.Brain Behav. 2024 Jan;14(1):e3372. doi: 10.1002/brb3.3372. Brain Behav. 2024. PMID: 38376025 Free PMC article.
-
Potential challenges to harmonize post-stroke cognitive assessment and its prognostic value: a narrative review.J Med Life. 2024 Nov;17(11):963-977. doi: 10.25122/jml-2024-0284. J Med Life. 2024. PMID: 39781311 Free PMC article. Review.
References
-
- Mijajlovic MD, Pavlovic A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB et al (2017) Post-stroke dementia - a comprehensive review. BMC Med 15(1):11. https://doi.org/10.1186/s12916-017-0779-7 - DOI - PubMed - PMC
-
- Kim KY, Shin KY, Chang KA (2022) Potential biomarkers for post-stroke cognitive impairment: a systematic review and meta-analysis. Int J Mol Sci 23(2). https://doi.org/10.3390/ijms23020602
-
- Huang YY, Chen SD, Leng XY, Kuo K, Wang ZT, Cui M et al (2022) Post-stroke cognitive impairment: epidemiology, risk factors, and management. J Alzheimers Dis 86(3):983–999. https://doi.org/10.3233/JAD-215644 - DOI - PubMed
-
- Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: the role of iron. Glia 57(5):467–478. https://doi.org/10.1002/glia.20784 - DOI - PubMed
-
- Gleason A, Bush AI (2021) Iron and ferroptosis as therapeutic targets in alzheimer's disease. Neurotherapeutics 18(1):252–264. https://doi.org/10.1007/s13311-020-00954-y - DOI - PubMed
LinkOut - more resources
Full Text Sources